National Health Investors, Inc. (NHI) Announces Quarterly Earnings Results
National Health Investors, Inc. (NYSE:NHI) released its quarterly earnings results on Wednesday. The real estate investment trust reported $0.93 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.29 by $0.36, MarketWatch Earnings reports. National Health Investors had a net margin of 63.72% and a return on equity of 13.36%. The company had revenue of $69.84 million for the quarter, compared to the consensus estimate of $67.68 million. During the same period in the prior year, the firm posted $1.22 EPS. The business’s revenue for the quarter was up 14.1% on a year-over-year basis. National Health Investors updated its FY17 guidance to $5.22-5.26 EPS.
National Health Investors (NYSE NHI) traded up 0.75% during trading on Thursday, hitting $76.63. The stock had a trading volume of 13,137 shares. National Health Investors has a 52-week low of $66.31 and a 52-week high of $82.53. The company has a market cap of $3.14 billion, a price-to-earnings ratio of 18.61 and a beta of 0.56. The firm’s 50-day moving average price is $77.50 and its 200-day moving average price is $75.01.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 10th. Stockholders of record on Friday, September 29th will be paid a $0.95 dividend. This represents a $3.80 dividend on an annualized basis and a dividend yield of 5.00%. The ex-dividend date is Thursday, September 28th. National Health Investors’s dividend payout ratio (DPR) is 92.23%.
Several analysts have issued reports on the company. BidaskClub lowered National Health Investors from a “hold” rating to a “sell” rating in a report on Wednesday. Bank of America Corporation lowered National Health Investors from a “neutral” rating to an “underperform” rating and set a $76.00 price target for the company. in a report on Monday, May 22nd. ValuEngine lowered National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, June 13th. Zacks Investment Research raised National Health Investors from a “hold” rating to a “buy” rating and set a $81.00 price target for the company in a report on Wednesday, May 10th. Finally, Stifel Nicolaus boosted their price target on National Health Investors from $80.00 to $82.00 and gave the company a “buy” rating in a report on Wednesday, June 21st. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $79.60.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Stock Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related stocks with our FREE daily email newsletter.